Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,830 | -8,547 | -3,597 | -25,469 | -24,698 |
| Depreciation Amortization | 1,623 | 869 | 339 | 632 | 367 |
| Accounts receivable | N/A | N/A | N/A | -4,055 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 1,257 | N/A |
| Other Working Capital | -14,792 | -20,250 | -13,455 | -32,121 | -18,827 |
| Other Operating Activity | 3,520 | 3,019 | 1,582 | 7,289 | 4,665 |
| Operating Cash Flow | $-32,479 | $-24,909 | $-15,131 | $-52,467 | $-38,493 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,148 | -2,988 | -1,927 | -2,462 | -1,286 |
| Purchase Of Investment | -41,178 | -38,525 | -26,032 | -59,317 | -48,762 |
| Sale Of Investment | 67,687 | 47,523 | 28,373 | 71,617 | 61,767 |
| Investing Cash Flow | $24,361 | $6,010 | $414 | $9,838 | $11,719 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,040 | 416 | N/A | 32,166 | 501 |
| Financing Cash Flow | $10,040 | $416 | $N/A | $32,166 | $501 |
| Exchange Rate Effect | 2,708 | 525 | -112 | -2,144 | -2,526 |
| Beginning Cash Position | 62,260 | 62,260 | 62,260 | 74,867 | 74,867 |
| End Cash Position | 66,890 | 44,302 | 47,431 | 62,260 | 46,068 |
| Net Cash Flow | $4,630 | $-17,958 | $-14,829 | $-12,607 | $-28,799 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,479 | -24,909 | -15,131 | -52,467 | -38,493 |
| Capital Expenditure | -2,148 | -2,988 | -1,927 | -2,462 | -1,286 |
| Free Cash Flow | -34,627 | -27,897 | -17,058 | -54,929 | -39,779 |